The decreased expression of RASSF1A was accompanied by promoter methylation in 71 % NSCLC samples, in case of FUS1 it was found in 20 % NSCLC specimens, and only in 5 % NSCLC samples for NPRL2/G21. Here, RASSF1 is linked to non-small cell lung carcinoma.